Guido Eibl

5.4k total citations · 1 hit paper
102 papers, 4.1k citations indexed

About

Guido Eibl is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Guido Eibl has authored 102 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 41 papers in Molecular Biology and 37 papers in Surgery. Recurrent topics in Guido Eibl's work include Pancreatitis Pathology and Treatment (28 papers), Pancreatic and Hepatic Oncology Research (28 papers) and Inflammatory mediators and NSAID effects (16 papers). Guido Eibl is often cited by papers focused on Pancreatitis Pathology and Treatment (28 papers), Pancreatic and Hepatic Oncology Research (28 papers) and Inflammatory mediators and NSAID effects (16 papers). Guido Eibl collaborates with scholars based in United States, Germany and Japan. Guido Eibl's co-authors include O. Joe Hines, Howard A. Reber, Enrique Rozengurt, James Sinnett‐Smith, Krisztina Kisfalvi, John P. Duffy, H. J. Buhr, Aune Moro, Hui-Hua Chang and Hubert G. Hotz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Guido Eibl

100 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer

2017 324 citations Dana K. Andersen, Murray Korc et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guido Eibl United States	39	2.0k	1.8k	1.2k	839	458	102	4.1k
Yanqiao Zhang China	31	1.8k 0.9×	1.9k 1.1×	1.0k 0.8×	963 1.1×	789 1.7×	154	4.3k
Shigeki Nakagawa Japan	38	1.8k 0.9×	1.7k 0.9×	1.2k 0.9×	994 1.2×	664 1.4×	184	4.9k
Keizo Kanasaki Japan	49	795 0.4×	2.4k 1.4×	839 0.7×	747 0.9×	979 2.1×	143	6.6k
Junji Matsui Japan	31	1.8k 0.9×	2.0k 1.1×	730 0.6×	842 1.0×	1.2k 2.7×	91	5.7k
Takashi Kobayashi Japan	30	1.1k 0.6×	1.2k 0.7×	1.5k 1.2×	450 0.5×	490 1.1×	262	3.7k
Sang Cheul Oh South Korea	35	2.1k 1.1×	1.9k 1.1×	918 0.7×	738 0.9×	323 0.7×	192	4.9k
Zheng Wu China	34	996 0.5×	1.4k 0.8×	657 0.5×	825 1.0×	448 1.0×	149	3.2k
Goshi Shiota Japan	41	788 0.4×	2.2k 1.3×	1.2k 1.0×	843 1.0×	1.6k 3.5×	165	5.4k
Satoshi Kobayashi Japan	30	1.1k 0.6×	1.0k 0.6×	768 0.6×	255 0.3×	326 0.7×	213	3.3k
Aurelia Lugea United States	36	1.8k 0.9×	1.2k 0.7×	2.4k 1.9×	357 0.4×	950 2.1×	81	4.4k

Countries citing papers authored by Guido Eibl

Since Specialization

Citations

This map shows the geographic impact of Guido Eibl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Eibl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Eibl more than expected).

Fields of papers citing papers by Guido Eibl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Eibl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Eibl. The network helps show where Guido Eibl may publish in the future.

Co-authorship network of co-authors of Guido Eibl

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Eibl. A scholar is included among the top collaborators of Guido Eibl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Eibl. Guido Eibl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sun, Xiaoying, Yaroslav Teper, James Sinnett‐Smith, et al.. (2024). Stress and Obesity Signaling Converge on CREB Phosphorylation to Promote Pancreatic Cancer. Molecular Cancer Research. 23(3). 236–249. 4 indexed citations

Sinnett‐Smith, James, et al.. (2022). Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells: Implications for Targeted Therapy. Molecular Cancer Therapeutics. 21(11). 1652–1662. 10 indexed citations

Saint‐Maurice, Pedro F., et al.. (2022). Body Mass Index Trajectories Across the Adult Life Course and Pancreatic Cancer Risk. JNCI Cancer Spectrum. 6(6). 7 indexed citations

Eibl, Guido, et al.. (2019). Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development. World Journal of Gastroenterology. 25(15). 1797–1816. 18 indexed citations

Abbruzzese, James L., Dana K. Andersen, Carl Borrebaeck, et al.. (2018). The Interface of Pancreatic Cancer With Diabetes, Obesity, and Inflammation: Research Gaps and Opportunities. Pancreas. 47(5). 516–525. 44 indexed citations

Chang, Hui-Hua, Aune Moro, David W. Dawson, et al.. (2018). Metformin Decreases the Incidence of Pancreatic Ductal Adenocarcinoma Promoted by Diet-induced Obesity in the Conditional KrasG12D Mouse Model. Scientific Reports. 8(1). 5899–5899. 32 indexed citations

Eibl, Guido & Enrique Rozengurt. (2017). KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops. Seminars in Cancer Biology. 54. 50–62. 60 indexed citations

Kisfalvi, Krisztina, Aune Moro, James Sinnett‐Smith, Guido Eibl, & Enrique Rozengurt. (2013). Metformin Inhibits the Growth of Human Pancreatic Cancer Xenografts. Pancreas. 42(5). 781–785. 74 indexed citations

Donahue, Timothy R., O. Joe Hines, James J. Farrell, et al.. (2010). Cystic Neoplasms of the Pancreas. Pancreas. 39(8). 1271–1276. 20 indexed citations

10.

Angst, Eliane, et al.. (2010). Bioluminescence Imaging of Angiogenesis in a Murine Orthotopic Pancreatic Cancer Model. Molecular Imaging and Biology. 12(6). 570–575. 13 indexed citations

11.

Kisfalvi, Krisztina, Guido Eibl, James Sinnett‐Smith, & Enrique Rozengurt. (2009). Metformin Disrupts Crosstalk between G Protein–Coupled Receptor and Insulin Receptor Signaling Systems and Inhibits Pancreatic Cancer Growth. Cancer Research. 69(16). 6539–6545. 258 indexed citations

12.

King, Jonathan C., Guido Eibl, Mark Sugi, et al.. (2009). 57: Dual Inhibition of CXCR2 and VEGFR2 Blocks Pancreatic Cancer Growth. Journal of Surgical Research. 151(2). 196–196. 1 indexed citations

13.

Eibl, Guido. (2008). The Role of PPAR‐γ and Its Interaction with COX‐2 in Pancreatic Cancer. PPAR Research. 2008(1). 326915–326915. 26 indexed citations

14.

Guha, Sushovan, Guido Eibl, Krisztina Kisfalvi, et al.. (2005). Broad-Spectrum G Protein–Coupled Receptor Antagonist, [D-Arg1,D-Trp5,7,9,Leu11]SP: A Dual Inhibitor of Growth and Angiogenesis in Pancreatic Cancer. Cancer Research. 65(7). 2738–2745. 86 indexed citations

15.

Okada, Yuji, Guido Eibl, John P. Duffy, Howard A. Reber, & O. Joe Hines. (2003). Glial cell-derived neurotrophic factor upregulates the expression and activation of matrix metalloproteinase-9 in human pancreatic cancer. Surgery. 134(2). 293–299. 61 indexed citations

16.

Eibl, Guido, Moritz N. Wente, Howard A. Reber, & O. Joe Hines. (2001). Peroxisome Proliferator-Activated Receptor γ Induces Pancreatic Cancer Cell Apoptosis. Biochemical and Biophysical Research Communications. 287(2). 522–529. 92 indexed citations

17.

Eibl, Guido, et al.. (2000). Effect of Fluid Resuscitation with and without Endothelin A Receptor Blockade on Hemoconcentration and Organ Function in Experimental Pancreatitis. European Surgical Research. 32(3). 162–168. 26 indexed citations

18.

Foitzik, Thomas, Guido Eibl, & H. J. Buhr. (2000). Therapy for microcirculatory disorders in severe acute pancreatitis: comparison of delayed therapy with ICAM-1 antibodies and a specific endothelin a receptor antagonist. Journal of Gastrointestinal Surgery. 4(3). 240–247. 28 indexed citations

19.

Germer, C.-T., et al.. (1998). [Value of magnetic resonance tomography in preoperative staging of stomach carcinoma].. PubMed. 115. 1367–9. 1 indexed citations

20.

Eibl, Guido, C. T. Germer, & H. J. Buhr. (1998). Monströse Pseudocyste der Nebenniere. Der Chirurg. 69(3). 298–300. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact